Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets

Area of Science:

• Cardiovascular Science
• Inflammation Research
• Medical Therapeutics

Background:

• Atherosclerosis is a leading cause of global mortality, accounting for approximately one in three deaths.
• Rising obesity and diabetes prevalence are projected to increase cardiovascular disease (CVD) burden.
• Existing atherosclerosis treatments primarily focus on lipid management, leaving significant residual risk and side effects.

Purpose of the Study:

• To review the critical role of cytokines in atherosclerotic disease progression.
• To explore potential therapeutic strategies targeting cytokines for atherosclerosis treatment.

Main Methods:

• Literature review focusing on inflammatory cytokines in atherosclerosis.
• Analysis of current therapeutic approaches and their limitations.
• Identification of novel cytokine-targeted interventions.

Main Results:

• Cytokines are key mediators in the inflammatory processes driving atherosclerosis.
• Targeting specific cytokines presents a viable alternative to lipid-modulating therapies.
• Emerging strategies aim to regulate inflammatory pathways for atherogenesis control.

Conclusions:

• Cytokine-centric therapies hold potential for improved atherosclerosis management.
• Modulating inflammation offers a complementary approach to lipid homeostasis in CVD prevention.
• Further research into cytokine pathways can lead to innovative treatments for cardiovascular disease.